Etid klinik pou Asm nan Illinois
10 etid pou Asm ap chèche patisipan nan sit nan Illinois.
Vil nan Illinois
Tèks ofisyèl etid la (Anglè)
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Normal
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT05757102ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Maryville
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT07301255A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Christie Clinic - University, Champaign
- Innovo Research - Christie Clinic, Champaign
- Christie Clinic - Windsor, Champaign
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 22, 2026 · NCT06977581A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Axis Clinical Trials - Westchester, Westchester
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07219173A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 31, Glenview
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07276724A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12162, Westchester
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT06664619Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT05272241Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Normal
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Aug 13, 2026 · NCT06307665A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Chicago
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07532265Protocol CAUSE-03 / CHEETAH
- Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 6 a 17 · Tout sèks · Mizajou Jul 1, 2026 · NCT06136091Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.